{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:51:08Z","timestamp":1767034268282},"reference-count":9,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2023.19336","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T17:34:16Z","timestamp":1687368856000},"page":"e2319336","source":"Crossref","is-referenced-by-count":8,"title":["Ambroxol as Therapy for Gaucher Disease\u2014Ambitious but Ambivalent"],"prefix":"10.1001","volume":"6","author":[{"given":"Neal J.","family":"Weinreb","sequence":"first","affiliation":[{"name":"Department of Human Genetics, University of Miami Miller School of Medicine, Boca Raton, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Goker-Alpan","sequence":"additional","affiliation":[{"name":"Lysosomal and Rare Diseases Research and Treatment Center, Fairfax, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"issue":"6","key":"zic230097r1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.19364","article-title":"Use of ambroxol as therapy for Gaucher disease.","volume":"6","author":"Zhan","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zic230097r2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247211","article-title":"Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease.","volume":"16","author":"Ivanova","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"zic230097r3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00109-021-02174-z","article-title":"Gaucher disease: more than just a rare lipid storage disease.","volume":"100","author":"Roh","year":"2022","journal-title":"J Mol Med (Berl)"},{"issue":"7","key":"zic230097r4","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.3390\/ijms23073536","article-title":"Mechanistic insight into the mode of action of acid \u00df-glucosidase enhancer ambroxol.","volume":"23","author":"Pantoom","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"35","key":"zic230097r5","doi-asserted-by":"publisher","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease.","volume":"284","author":"Maegawa","year":"2009","journal-title":"J Biol Chem"},{"issue":"11","key":"zic230097r6","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1016\/j.ymgme.2017.12.170","article-title":"Individualized screening for chaperone activity in Gaucher disease using multiple patient derived primary cell lines.","volume":"10","author":"Ivanova","year":"2018","journal-title":"Am J Transl Res"},{"issue":"7","key":"zic230097r7","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.3390\/ijms24076732","article-title":"High-dose ambroxol therapy in type 1 Gaucher disease focusing on patients with poor response to enzyme replacement therapy or substrate reduction therapy.","volume":"24","author":"Istaiti","year":"2023","journal-title":"Int J Mol Sci"},{"key":"zic230097r8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.907317","article-title":"Promising effect of high dose ambroxol treatment on neurocognition and motor development in a patient with neuropathic Gaucher disease 2.","volume":"13","author":"Aries","year":"2022","journal-title":"Front Neurol"},{"key":"zic230097r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2020.100678","article-title":"In vitro and in vivo effects of ambroxol chaperone therapy in two Italian patients affected by neuronopathic Gaucher disease and epilepsy.","volume":"25","author":"Ciana","year":"2020","journal-title":"Mol Genet Metab Rep"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2806327\/weinreb_2023_ic_230097_1686670858.13397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T13:18:29Z","timestamp":1702646309000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2806327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.19336","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]}}}